358 related articles for article (PubMed ID: 34049488)
1. Myocardial fibrosis combined with NT-proBNP improves the accuracy of survival prediction in ADHF patients.
Yao Y; Feng L; Sun Y; Wang S; Sun J; Hu B
BMC Cardiovasc Disord; 2021 May; 21(1):264. PubMed ID: 34049488
[TBL] [Abstract][Full Text] [Related]
2. Clinical utility of N-terminal pro-B-type natriuretic peptide for risk stratification of patients with acute decompensated heart failure. Derivation and validation of the ADHF/NT-proBNP risk score.
Scrutinio D; Ammirati E; Guida P; Passantino A; Raimondo R; Guida V; Sarzi Braga S; Pedretti RF; Lagioia R; Frigerio M; Catanzaro R; Oliva F
Int J Cardiol; 2013 Oct; 168(3):2120-6. PubMed ID: 23395457
[TBL] [Abstract][Full Text] [Related]
3. A novel discharge risk model for patients hospitalised for acute decompensated heart failure incorporating N-terminal pro-B-type natriuretic peptide levels: a European coLlaboration on Acute decompeNsated Heart Failure: ELAN-HF Score.
Salah K; Kok WE; Eurlings LW; Bettencourt P; Pimenta JM; Metra M; Bayes-Genis A; Verdiani V; Bettari L; Lazzarini V; Damman P; Tijssen JG; Pinto YM
Heart; 2014 Jan; 100(2):115-25. PubMed ID: 24179162
[TBL] [Abstract][Full Text] [Related]
4. Soluble ST2, high-sensitivity troponin T- and N-terminal pro-B-type natriuretic peptide: complementary role for risk stratification in acutely decompensated heart failure.
Pascual-Figal DA; Manzano-Fernández S; Boronat M; Casas T; Garrido IP; Bonaque JC; Pastor-Perez F; Valdés M; Januzzi JL
Eur J Heart Fail; 2011 Jul; 13(7):718-25. PubMed ID: 21551163
[TBL] [Abstract][Full Text] [Related]
5. sST2 Predicts Outcome in Chronic Heart Failure Beyond NT-proBNP and High-Sensitivity Troponin T.
Emdin M; Aimo A; Vergaro G; Bayes-Genis A; Lupón J; Latini R; Meessen J; Anand IS; Cohn JN; Gravning J; Gullestad L; Broch K; Ueland T; Nymo SH; Brunner-La Rocca HP; de Boer RA; Gaggin HK; Ripoli A; Passino C; Januzzi JL
J Am Coll Cardiol; 2018 Nov; 72(19):2309-2320. PubMed ID: 30384887
[TBL] [Abstract][Full Text] [Related]
6. Cystatin C-based CKD-EPI equations and N-terminal pro-B-type natriuretic peptide for predicting outcomes in acutely decompensated heart failure.
Flores-Blanco PJ; Manzano-Fernández S; Pérez-Calvo JI; Pastor-Pérez FJ; Ruiz-Ruiz FJ; Carrasco-Sánchez FJ; Morales-Rull JL; Pascual-Figal D; Galisteo-Almeda L; Januzzi JL
Clin Cardiol; 2015 Feb; 38(2):106-13. PubMed ID: 25663560
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of collagen turnover biomarkers in cardiac resynchronization therapy: A subanalysis of the TRUST CRT randomized trial population.
Sokal A; Lenarczyk R; Kowalski O; Mitrega K; Pluta S; Stabryla-Deska J; Streb W; Urbanik Z; Krzeminski TF; Kalarus Z
Heart Rhythm; 2016 May; 13(5):1088-1095. PubMed ID: 26776557
[TBL] [Abstract][Full Text] [Related]
8. Incremental value of biomarkers to clinical variables for mortality prediction in acutely decompensated heart failure: the Multinational Observational Cohort on Acute Heart Failure (MOCA) study.
Lassus J; Gayat E; Mueller C; Peacock WF; Spinar J; Harjola VP; van Kimmenade R; Pathak A; Mueller T; Disomma S; Metra M; Pascual-Figal D; Laribi S; Logeart D; Nouira S; Sato N; Potocki M; Parenica J; Collet C; Cohen-Solal A; Januzzi JL; Mebazaa A;
Int J Cardiol; 2013 Oct; 168(3):2186-94. PubMed ID: 23538053
[TBL] [Abstract][Full Text] [Related]
9. Serum levels of carbohydrate antigen 125 in combination with N-terminal pro-brain natriuretic peptide in patients with acute decompensated heart failure.
Yoon JY; Yang DH; Cho HJ; Kim NK; Kim CY; Son J; Roh JH; Jang SY; Bae MH; Lee JH; Park HS; Cho Y; Chae SC
Korean J Intern Med; 2019 Jul; 34(4):811-818. PubMed ID: 30616330
[TBL] [Abstract][Full Text] [Related]
10. [Soluble Suppression of Tumorogenicity 2 Increases Opportunities for Risk Stratification After Acute Heart Failure Decompensation].
Skvortsov AA; Protasov VN; Narusov OY; Koshkina DE; Nasonova SN; Masenko VP; Tereschenko SN
Kardiologiia; 2017 Jan; (1):48-58. PubMed ID: 28290833
[TBL] [Abstract][Full Text] [Related]
11. Competing Risk of Cardiac Status and Renal Function During Hospitalization for Acute Decompensated Heart Failure.
Salah K; Kok WE; Eurlings LW; Bettencourt P; Pimenta JM; Metra M; Verdiani V; Tijssen JG; Pinto YM
JACC Heart Fail; 2015 Oct; 3(10):751-61. PubMed ID: 26449995
[TBL] [Abstract][Full Text] [Related]
12. Superior prognostic value of soluble suppression of tumorigenicity 2 for the short-term mortality of maintenance hemodialysis patients compared with NT-proBNP: a prospective cohort study.
Wang Z; Chen Z; Yu H; Ma X; Zhang C; Qu B; Zhang W; Chen X
Ren Fail; 2020 Nov; 42(1):523-530. PubMed ID: 32460670
[No Abstract] [Full Text] [Related]
13. Carbohydrate antigen-125 and N-terminal pro-brain natriuretic peptide levels: compared in heart-failure prognostication.
Ordu S; Ozhan H; Alemdar R; Aydin M; Caglar O; Yuksel H; Kandis H
Tex Heart Inst J; 2012; 39(1):30-5. PubMed ID: 22412224
[TBL] [Abstract][Full Text] [Related]
14. Direct comparison of serial B-type natriuretic peptide and NT-proBNP levels for prediction of short- and long-term outcome in acute decompensated heart failure.
Noveanu M; Breidthardt T; Potocki M; Reichlin T; Twerenbold R; Uthoff H; Socrates T; Arenja N; Reiter M; Meissner J; Heinisch C; Stalder S; Mueller C
Crit Care; 2011; 15(1):R1. PubMed ID: 21208408
[TBL] [Abstract][Full Text] [Related]
15. Single sST2 protein measurement predicts adverse outcomes at 1-year follow-up in patients with chronic heart failure.
Sobczak S; Wojtczak-Soska K; Ciurus T; Sakowicz A; Pietrucha T; Lelonek M
Pol Arch Med Wewn; 2014; 124(9):452-8. PubMed ID: 25041760
[TBL] [Abstract][Full Text] [Related]
16. NT-proBNP (N-Terminal pro-B-Type Natriuretic Peptide)-Guided Therapy in Acute Decompensated Heart Failure: PRIMA II Randomized Controlled Trial (Can NT-ProBNP-Guided Therapy During Hospital Admission for Acute Decompensated Heart Failure Reduce Mortality and Readmissions?).
Stienen S; Salah K; Moons AH; Bakx AL; van Pol P; Kortz RAM; Ferreira JP; Marques I; Schroeder-Tanka JM; Keijer JT; Bayés-Genis A; Tijssen JGP; Pinto YM; Kok WE
Circulation; 2018 Apr; 137(16):1671-1683. PubMed ID: 29242350
[TBL] [Abstract][Full Text] [Related]
17. N-Terminal Pro-B-Type Natriuretic Peptide (NT-proBNP) Measurements Until a 30% Reduction Is Attained During Acute Decompensated Heart Failure Admissions and Comparison With Discharge NT-proBNP Levels: Implications for In-Hospital Guidance of Treatment.
Stienen S; Salah K; Dickhoff C; Carubelli V; Metra M; Magrini L; Di Somma S; Tijssen JP; Pinto YM; Kok WE
J Card Fail; 2015 Nov; 21(11):930-4. PubMed ID: 26216495
[TBL] [Abstract][Full Text] [Related]
18. [Comparative prognostic value of plasma and urinary N-terminal pro-B-type natriuretic peptide in patients with acute destabilized heart failure].
Manzano-Fernández S; Januzzi JL; Boronat García M; Bonaque-González JC; Muñoz-Esparza C; Albaladejo-Otón MD; Pastor-Pérez FJ; Pastor P; Valdés M; Pascual-Figal DA
Rev Esp Cardiol; 2011 May; 64(5):365-72. PubMed ID: 21397374
[TBL] [Abstract][Full Text] [Related]
19. Combined use of high-sensitivity ST2 and NT-proBNP for predicting major adverse cardiovascular events in coronary heart failure.
Bai J; Han L; Liu H
Ann Palliat Med; 2020 Jul; 9(4):1976-1989. PubMed ID: 32762223
[TBL] [Abstract][Full Text] [Related]
20. Comparison of predictive value of NT-proBNP, sST2 and MMPs in heart failure patients with different ejection fractions.
Pan W; Yang D; Yu P; Yu H
BMC Cardiovasc Disord; 2020 Apr; 20(1):208. PubMed ID: 32354356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
